We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+6.27%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$585B
AUM Growth
+$29.3B
Cap. Flow
+$1.02B
Cap. Flow %
0.17%
Top 10 Hldgs %
17.95%
Holding
2,642
New
88
Increased
1,025
Reduced
900
Closed
73

Top Buys

Rank Stock Value
1
GEN icon
Gen Digital
GEN
+$2.03B
2
DD icon
DuPont de Nemours
DD
+$1.83B
3
CCI icon
Crown Castle
CCI
+$1.58B
4
MSFT icon
Microsoft
MSFT
+$1.48B
5
TRU icon
TransUnion
TRU
+$781M

Sector Composition

Rank Sector Weight
1 Healthcare 17.59%
2 Financials 16.53%
3 Technology 15%
4 Consumer Discretionary 13.37%
5 Industrials 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FRME icon
1751
First Merchants
FRME
$2.72B
$1.15M ﹤0.01%
26,782
-2,000
-7% -$79.6K
INSY
1752
DELISTED
Insys Therapeutics, Inc.
INSY
$1.15M ﹤0.01%
129,483
+850
+0.7% +$8.77K
MNR
1753
DELISTED
Monmouth Real Estate Investment Corp
MNR
$1.15M ﹤0.01%
71,033
+705
+1% +$11K
TXRH icon
1754
Texas Roadhouse
TXRH
$14.1B
$1.15M ﹤0.01%
23,387
LOPE icon
1755
Grand Canyon Education
LOPE
$3.7B
$1.15M ﹤0.01%
12,632
UBSI icon
1756
United Bankshares
UBSI
$6.66B
$1.15M ﹤0.01%
30,881
SGMO
1757
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$1.15M ﹤0.01%
76,300
-12,400
-14% -$137K
AKRX
1758
DELISTED
Akorn Inc
AKRX
$1.14M ﹤0.01%
34,358
+10
+0% +$332
AEL
1759
DELISTED
American Equity Investment Life Holding Company
AEL
$1.14M ﹤0.01%
39,069
+9,526
+32% +$263K
OKSB
1760
DELISTED
Southwest Bancorp Inc/OK
OKSB
$1.13M ﹤0.01%
41,156
ROG icon
1761
Rogers Corp
ROG
$2.48B
$1.13M ﹤0.01%
8,501
CVA
1762
DELISTED
Covanta Holding Corporation
CVA
$1.13M ﹤0.01%
76,233
HQY icon
1763
HealthEquity
HQY
$8.83B
$1.13M ﹤0.01%
22,340
+2,600
+13% +$121K
BPFH
1764
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
$1.13M ﹤0.01%
68,231
+2,731
+4% +$41.3K
CBI
1765
DELISTED
Chicago Bridge & Iron Nv
CBI
$1.13M ﹤0.01%
67,198
+18,635
+38% +$285K
MDR
1766
DELISTED
McDermott International
MDR
$1.12M ﹤0.01%
51,248
FULT icon
1767
Fulton Financial
FULT
$4.67B
$1.12M ﹤0.01%
59,599
+196
+0.3% +$3.52K
SPY icon
1768
State Street SPDR S&P 500 ETF Trust
SPY
$815B
$1.12M ﹤0.01%
4,447
NWBI icon
1769
Northwest Bancshares
NWBI
$2.31B
$1.11M ﹤0.01%
64,550
APOG icon
1770
Apogee Enterprises
APOG
$897M
$1.11M ﹤0.01%
23,070
+900
+4% +$44.2K
BTI icon
1771
British American Tobacco
BTI
$124B
$1.11M ﹤0.01%
+17,734
New +$1.14M
DOC
1772
DELISTED
PHYSICIANS REALTY TRUST
DOC
$1.11M ﹤0.01%
62,498
+4,462
+8% +$82.3K
CSR
1773
Centerspace
CSR
$925M
$1.09M ﹤0.01%
17,900
HMN icon
1774
Horace Mann Educators
HMN
$2.09B
$1.09M ﹤0.01%
27,623
-1,600
-5% -$58.9K
NVRO
1775
DELISTED
NEVRO CORP.
NVRO
$1.09M ﹤0.01%
11,958
-2,520
-17% -$216K

Similar funds

T. Rowe Price Associates's Q3 2017 Portfolio in Review

As of Q3 2017, T. Rowe Price Associates held 2,642 positions worth $585B, up 5.3% from $556B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

T. Rowe Price Associates's Q3 2017 filing shows 88 new, 1,025 increased, 900 reduced and 73 closed positions. Its largest new stake was Brighthouse Financial: 4,532,679 shares worth $276M. The largest sale was Du Pont De Nemours E I, an estimated $1.72B.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Financials and Technology.

  • T. Rowe Price Associates's largest Q3 2017 buy was Brighthouse Financial: 4,532,679 shares worth $276M.
  • T. Rowe Price Associates added most to Gen Digital in Q3 2017, an estimated $2.03B increase.
  • T. Rowe Price Associates's biggest Q3 2017 reduction was Starbucks, cutting an estimated $1.59B.
  • T. Rowe Price Associates fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $1.72B.
  • T. Rowe Price Associates's ten largest holdings make up 18% of its $585B portfolio in Q3 2017.
  • T. Rowe Price Associates opened 88 new positions and closed 73 in Q3 2017.
  • T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $585B.

Based on T. Rowe Price Associates's 13F filing for Q3 2017, filed 14 Nov 2017.